18.05

2.64% 0.48

Warby Parker Inc (WRBY)

Overview News Price History Option Chain Why WRBY Down? Discussions Forecast

Warby Parker Inc stock is traded at $18.05, with a volume of 1.05M. It is up +2.64% in the last 24 hours and up +12.01% over the past month. Warby Parker Inc is engaged in designing and developing designer prescription glasses and contacts, and providing the facility of eye exams and vision tests. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

Previous Close:

$17.57

Open:

$17.51

24h Volume:

1.05M

Relative Volume:

0.66

Market Cap:

$2.16B

Revenue:

$697.80M

Net Income/Loss:

$-55.06M

P/E Ratio:

-29.11

EPS:

-0.62

Net Cash Flow:

$16.55M

1W Performance:

+6.58%

1M Performance:

+12.01%

6M Performance:

+42.22%

1Y Performance:

+32.01%

1-Day Range:

$17.46

$18.19

1-Week Range:

$16.82

$18.19

52-Week Range:

$9.83

$18.37

Warby Parker Inc Stock (WRBY) Company Profile

Name

Warby Parker Inc

Sector

Healthcare (1181)

Industry

Medical Instruments & Supplies (58)

Phone

(646) 847-7215

Address

233 SPRING STREET, NEW YORK

Employee

3,491

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

WRBY's Discussions on Twitter

Warby Parker Inc Stock (WRBY) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-12-23	Upgrade	BTIG Research	Neutral → Buy
Oct-03-23	Upgrade	Evercore ISI	In-line → Outperform
Sep-25-23	Initiated	UBS	Neutral
Jun-27-23	Initiated	William Blair	Mkt Perform
May-24-23	Initiated	JMP Securities	Mkt Perform
Mar-01-23	Downgrade	Citigroup	Buy → Neutral
Feb-07-23	Initiated	BTIG Research	Neutral
Dec-15-22	Initiated	Wolfe Research	Outperform
Jul-22-22	Initiated	Piper Sandler	Overweight
May-18-22	Downgrade	Goldman	Buy → Neutral
Mar-31-22	Initiated	Stifel	Hold
Oct-26-21	Initiated	Citigroup	Buy
Oct-25-21	Initiated	Cowen	Outperform
Oct-25-21	Initiated	Evercore ISI	In-line
Oct-25-21	Initiated	Goldman	Buy
Oct-25-21	Initiated	Morgan Stanley	Equal-Weight
Oct-25-21	Initiated	Robert W. Baird	Outperform
Oct-25-21	Initiated	Telsey Advisory Group	Outperform

View All

Warby Parker Inc Stock (WRBY) Latest News

01:14 AM

Warby Parker Prevails Against 1-800 Contacts In Keyword Advertising Dispute - Marketscreener.com

01:14 AM

Nov 04, 2024

When Will Warby Parker Inc. (NYSE:WRBY) Breakeven? - Yahoo Finance

Nov 04, 2024

Nov 01, 2024

BTIG Research Forecasts Strong Price Appreciation for Warby Parker (NYSE:WRBY) Stock - MarketBeat

Nov 01, 2024

Oct 31, 2024

Warby Parker (NYSE:WRBY) Earns "Outperform" Rating from Telsey Advisory Group - MarketBeat

Oct 31, 2024

Warby Parker Prevails Against 1-800 Contacts in Keyword Advertising Dispute - The National Law Review

Oct 31, 2024

Warby Parker (WRBY) Set to Announce Quarterly Earnings on Thursday - MarketBeat

Oct 31, 2024

Oct 30, 2024

Citi raises sales growth concerns for Warby Parker, holds Neutral rating - Investing.com Australia

Oct 30, 2024

Oct 29, 2024

Hollywood teams up with Warby Parker for a good cause - AOL

Oct 29, 2024

Brokerages Set Warby Parker Inc. (NYSE:WRBY) Target Price at $17.00 - MarketBeat

Oct 29, 2024

Oct 27, 2024

Warby Parker to Announce Third Quarter 2024 Financial Results November 7, 2024 - Marketscreener.com

Oct 27, 2024

Oct 26, 2024

Warby Parker gains after attracting a bull call from Goldman Sachs - MSN

Oct 26, 2024

Oct 25, 2024

Vision-care company Warby Parker to open store in Fayetteville in early 2025 - The Central New York Business Journal

Oct 25, 2024

Zweig DiMenna Associates LLC Boosts Stake in Warby Parker Inc. (NYSE:WRBY) - MarketBeat

Oct 25, 2024

Oct 24, 2024